Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Iron dextran
Drug ID BADD_D01198
Description Iron dextran is a dark brown, slightly viscous liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. Iron Dextran is used for the treatment of patients with documented iron deficiency in which oral administration is unsatisfactory or impossible.
Indications and Usage For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.
Marketing Status approved; vet_approved
ATC Code Not Available
DrugBank ID DB00893
KEGG ID D02141
MeSH ID D007505
PubChem ID 105075
TTD Drug ID D08OKJ
NDC Product Code 0404-9879; 52584-086; 51662-1441; 12666-0020; 0023-6082
UNII 95HR524N2M
Synonyms Iron-Dextran Complex | Iron Dextran Complex | Ferridextran | Dextran-Iron Complex | Dextran Iron Complex | InFed | Norferan | Dexferrum | Imperon | Feosol | Hematran | Icar | Imfergen | Imferon | Imposil | Dextrofer
Chemical Information
Molecular Formula FeH2O4S
CAS Registry Number 9004-66-4
SMILES OS(=O)(=O)O.[Fe]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abscess sterile08.01.05.008--Not Available
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Asthenia08.01.01.001--Not Available
Back pain15.03.04.005--
Bradycardia02.03.02.002--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Cardiac arrest02.03.04.001--
Cellulitis23.11.02.004; 11.02.01.001--Not Available
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.009--Not Available
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.001--
Circulatory collapse24.06.02.001--Not Available
Cyanosis23.06.04.005; 02.11.04.004; 24.03.01.007; 22.02.02.007--
Diarrhoea07.02.01.001--
Disorientation17.02.05.015; 19.13.01.002--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspnoea02.11.05.003; 22.02.01.004--
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Haematuria21.10.01.018; 24.07.01.047; 20.02.01.006--
Headache17.14.01.001--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypertension24.08.02.001--
Hypoaesthesia17.02.06.023; 23.03.03.081--Not Available
Hypotension24.06.03.002--
Injection site pain12.07.03.011; 08.02.03.010--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages